Aadi Bioscience (AADI) Short Interest Ratio & Short Volume $1.98 -0.07 (-3.41%) As of 03/24/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aadi Bioscience Short Interest DataAadi Bioscience (AADI) has a short interest of 793,900 shares, representing 6.58% of the float (the number of shares available for trading by the public). This marks a 3.86% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 245,200 shares to cover all short positions.Current Short Interest793,900 sharesPrevious Short Interest764,400 sharesChange Vs. Previous Month+3.86%Dollar Volume Sold Short$2.03 millionShort Interest Ratio2.2 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares24,697,000 sharesFloat Size12,070,000 sharesShort Percent of Float6.58%Today's Trading Volume113,251 sharesAverage Trading Volume245,200 sharesToday's Volume Vs. Average46% Short Selling Aadi Bioscience? Sign up to receive the latest short interest report for Aadi Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAADI Short Interest Over TimeAADI Days to Cover Over TimeAADI Percentage of Float Shorted Over Time Remove Ads Aadi Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2025793,900 shares $2.03 million +3.9%6.6%2.2 $2.56 2/15/2025764,400 shares $1.98 million +8.2%4.2%2.2 $2.59 1/31/2025706,400 shares $2.03 million +49.4%3.5%2 $2.88 1/15/2025472,700 shares $1.53 million -13.7%2.3%1.4 $3.24 12/31/2024547,500 shares $1.72 million +136.0%2.7%1.7 $3.15 12/15/2024232,000 shares $559,120.00 +3.6%1.2%0.8 $2.41 11/30/2024224,000 shares $524,160.00 -12.7%1.1%1.8 $2.34 11/15/2024256,500 shares $541,215.00 -8.8%1.3%1.7 $2.11 10/31/2024281,100 shares $559,389.00 -0.9%1.6%1.3 $1.99 10/15/2024283,500 shares $603,855.00 -19.5%1.6%1.2 $2.13 Get the Latest News and Ratings for AADI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter. 9/30/2024352,200 shares $725,532.00 -10.6%2.0%1.5 $2.06 9/15/2024394,100 shares $709,380.00 +22.8%2.2%1.3 $1.80 8/31/2024320,900 shares $580,829.00 +6.1%1.8%1.1 $1.81 8/15/2024302,600 shares $438,770.00 +60.7%1.7%1.1 $1.45 7/31/2024188,300 shares $291,865.00 -19.3%1.1%0.9 $1.55 7/15/2024233,200 shares $347,468.00 -68.8%1.3%1.1 $1.49 6/30/2024747,000 shares $1.09 million -18.3%4.3%3.3 $1.46 6/15/2024914,400 shares $1.55 million +2.7%5.2%4.7 $1.69 5/31/2024890,000 shares $1.60 million -7.7%5.1%4.3 $1.80 5/15/2024964,000 shares $1.77 million -14.7%5.5%2.9 $1.84 4/30/20241,130,000 shares $2.17 million +2.7%6.5%3.3 $1.92 4/15/20241,100,000 shares $2.09 million +16.6%6.3%3.2 $1.90 3/31/2024943,100 shares $2.21 million -16.5%5.4%2.4 $2.34 3/15/20241,130,000 shares $2.45 million +19.0%6.5%2.6 $2.17 2/29/2024949,300 shares $1.87 million -4.1%5.5%1.7 $1.97 2/15/2024990,300 shares $1.88 million -13.1%5.7%2.2 $1.90 1/31/20241,140,000 shares $2.10 million +29.1%6.6%2.7 $1.84 1/15/2024883,200 shares $1.52 million +7.4%5.1%2.2 $1.72 12/31/2023822,200 shares $1.66 million +29.3%4.8%2.3 $2.02 12/15/2023635,900 shares $1.49 million -19.4%3.7%2.1 $2.34 11/30/2023789,000 shares $4.15 million +6.1%4.6%7.1 $5.26 11/15/2023743,700 shares $3.50 million -1.7%4.3%7 $4.71 10/31/2023756,600 shares $3.31 million -5.6%4.4%7 $4.38 10/15/2023801,300 shares $3.39 million +9.1%4.7%6.2 $4.23 9/30/2023734,700 shares $3.56 million +10.8%4.3%5.4 $4.84 9/15/2023662,900 shares $3.67 million +6.4%3.9%4.6 $5.54 8/31/2023623,300 shares $3.93 million -5.1%3.7%4.5 $6.30 8/15/2023656,500 shares $3.91 million -39.8%3.9%4.8 $5.95 7/31/20231,090,000 shares $5.81 million -4.4%6.4%8 $5.33 7/15/20231,140,000 shares $6.54 million +9.6%6.7%9 $5.74Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.There's no time to waste. As far as I can tell, the best way to profit from this project is to make 6/30/20231,040,000 shares $7.11 million -14.1%6.1%8.6 $6.84 6/15/20231,210,000 shares $9.92 million +11.0%7.2%9.3 $8.20 5/31/20231,090,000 shares $8.72 million -15.5%6.5%8.5 $8.00 5/15/20231,290,000 shares $9.07 million +17.3%7.7%9 $7.03 4/30/20231,100,000 shares $8.54 million -2.7%6.8%7.3 $7.76 4/15/20231,130,000 shares $9.14 million -27.6%7.0%8 $8.09 3/31/20231,560,000 shares $11.29 million +7.6%9.7%11.5 $7.24 3/15/20231,450,000 shares $11.63 million +22.9%9.0%12.1 $8.02 2/28/20231,180,000 shares $12.71 million +6.3%7.3%11.3 $10.77 2/15/20231,110,000 shares $13.18 million +2.8%6.9%11.8 $11.87 1/31/20231,080,000 shares $13.63 million +3.9%6.4%12.9 $12.62 1/15/20231,040,000 shares $13.47 million -11.9%6.1%11.7 $12.95 12/30/20221,180,000 shares $15.14 million +12.4%7.0%13.6 $12.83 12/15/20221,050,000 shares $13.34 million No Change6.2%11.6 $12.70 11/30/20221,050,000 shares $14.05 million -0.9%6.2%9.6 $13.38 11/15/20221,060,000 shares $14.21 million +13.0%6.3%9.2 $13.41 10/31/2022937,900 shares $12.11 million +27.6%6.1%8 $12.92 10/15/2022735,100 shares $9.27 million -2.1%5.5%6.2 $12.61 9/30/2022750,600 shares $10.61 million +2.0%5.6%6 $14.13 9/15/2022735,800 shares $9.39 million +5.6%6.3%4.5 $12.76 8/31/2022696,800 shares $9.44 million +8.9%6.0%4.6 $13.55 8/15/2022640,100 shares $8.94 million -8.0%5.5%4.4 $13.97 7/31/2022695,800 shares $8.61 million -4.3%6.3%4.6 $12.37 7/15/2022726,700 shares $9.35 million -3.4%6.6%5 $12.86 6/30/2022752,200 shares $9.27 million +9.3%6.8%5.2 $12.32 6/15/2022688,300 shares $9.26 million -12.3%6.2%5.2 $13.46 5/31/2022784,400 shares $12.64 million +23.8%7.1%7.7 $16.11 5/15/2022633,400 shares $8.88 million +23.4%5.7%6.2 $14.02 4/30/2022513,400 shares $7.50 million -13.2%4.7%5.2 $14.60 4/15/2022591,300 shares $9.76 million +2.9%5.4%5.3 $16.51 3/31/2022574,800 shares $9.75 million -18.8%5.3%4.6 $16.97 3/15/2022707,800 shares $12.18 million +5.1%6.5%5.4 $17.21 2/28/2022673,200 shares $11.73 million +7.3%6.2%4.1 $17.42 2/15/2022627,700 shares $12.59 million +1.6%5.8%3.1 $20.05 1/31/2022617,900 shares $11.74 million +0.3%5.9%2.9 $19.00 1/15/2022616,200 shares $15.10 million -2.6%5.9%3.1 $24.51 12/31/2021632,700 shares $15.28 million No Change6.0%3.5 $24.15 8/13/20212,750,000 shares $3.07 million -22.1%8.0%0.5 $1.12 7/30/20213,530,000 shares $7.13 million -17.7%10.4%0.4 $2.02 7/15/20214,290,000 shares $8.62 million +248.8%10.9%0.4 $2.01 6/30/20211,230,000 shares $2.08 million -31.7%3.1%0.1 $1.69 6/15/20211,800,000 shares $3.35 million -15.9%4.6%0.3 $1.86 5/28/20212,140,000 shares $3.64 million +103.8%5.5%0.4 $1.70 5/14/20211,050,000 shares $1.12 million -0.9%2.7%0.2 $1.07 4/30/20211,060,000 shares $1.24 million -15.2%2.7%0.7 $1.17 4/15/20211,250,000 shares $1.56 million +26.5%3.2%0.7 $1.25 3/31/2021988,400 shares $1.29 million -18.3%2.5%0.5 $1.31 3/15/20211,210,000 shares $1.96 million +133.3%3.1%0.5 $1.62 2/26/2021518,700 shares $918,099.00 -61.6%1.6%0.2 $1.77 2/12/20211,350,000 shares $2.71 million +8.9%4.0%0.5 $2.01Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.There's no time to waste. As far as I can tell, the best way to profit from this project is to make 1/29/20211,240,000 shares $1.55 million +42.7%3.1%0.5 $1.25 1/15/2021869,000 shares $1.06 million -37.0%2.2%0.4 $1.22 12/31/20201,380,000 shares $1.37 million +124.2%3.5%0.6 $0.99 12/15/2020615,400 shares $738,480.00 -65.2%1.6%0.3 $1.20 11/30/20201,770,000 shares $2.87 million +6.0%4.5%1.4 $1.62 11/15/20201,670,000 shares $2.81 million +6.4%4.3%1.4 $1.68 10/30/20201,570,000 shares $2.10 million -7.1%4.6%1.2 $1.34 10/15/20201,690,000 shares $2.35 million +15.0%4.9%0.8 $1.39 9/30/20201,470,000 shares $2.21 million +83.8%4.3%0.7 $1.50 9/15/2020800,000 shares $992,000.00 +117.9%2.3%0.4 $1.24 AADI Short Interest - Frequently Asked Questions What is Aadi Bioscience's current short interest? Short interest is the volume of Aadi Bioscience shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 793,900 shares of AADI short. 6.58% of Aadi Bioscience's shares are currently sold short. Learn More on Aadi Bioscience's current short interest. What is a good short interest ratio for Aadi Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AADI shares currently have a short interest ratio of 2.0. Learn More on Aadi Bioscience's short interest ratio. Which institutional investors are shorting Aadi Bioscience? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aadi Bioscience: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aadi Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.58% of Aadi Bioscience's floating shares are currently sold short. Is Aadi Bioscience's short interest increasing or decreasing? Aadi Bioscience saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 793,900 shares, an increase of 3.9% from the previous total of 764,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aadi Bioscience's float size? Aadi Bioscience currently has issued a total of 24,697,000 shares. Some of Aadi Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aadi Bioscience currently has a public float of 12,070,000 shares. How does Aadi Bioscience's short interest compare to its competitors? 6.58% of Aadi Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aadi Bioscience: MediWound Ltd. (12.91%), INmune Bio, Inc. (37.73%), Tevogen Bio Holdings Inc. (5.17%), Inhibrx, Inc. (11.96%), Checkpoint Therapeutics, Inc. (19.90%), 4D Molecular Therapeutics, Inc. (12.23%), Neumora Therapeutics, Inc. (21.93%), CARGO Therapeutics, Inc. (18.87%), Canopy Growth Co. (8.90%), Contineum Therapeutics, Inc. (6.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Aadi Bioscience stock? Short selling AADI is an investing strategy that aims to generate trading profit from Aadi Bioscience as its price is falling. AADI shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aadi Bioscience? A short squeeze for Aadi Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AADI, which in turn drives the price of the stock up even further. How often is Aadi Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AADI, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies MediWound Short Interest Data INmune Bio Short Interest Data Tevogen Bio Short Interest Data Inhibrx Short Interest Data Checkpoint Therapeutics Short Interest Data 4D Molecular Therapeutics Short Interest Data Neumora Therapeutics Short Interest Data CARGO Therapeutics Short Interest Data Canopy Growth Short Interest Data Contineum Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AADI) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AADI Stock Free AADI Stock Alerts